FDA to Review Clinical Studies of Safety and Effectiveness of Orphan Products, Announces Grant Availability and Calls for Applications

Summary

The US Food and Drug Administration (FDA) is seeking applications for clinical studies on orphan products, while also announcing the availability of grants to support these studies, which are expected to be reviewed in the coming months